IASLC World Conference on Lung Cancer (WCLC) - Korea

The World Conference on Lung Cancer (WCLC) in Korea is the largest academic conference in the global lung cancer field. Focusing on basic research, clinical treatment advancements, and the exploration of innovative therapies, it serves as a core platform driving the development of the lung cancer sector. Notably, an increasing number of research studies from China have been presented on this stage in recent years.

Organized by the International Association for the Study of Lung Cancer (IASLC), the World Conference on Lung Cancer (WCLC) stands as one of the most influential global academic events in the lung cancer field. WCLC is not only a premier academic hub for physicians to learn about cutting-edge advancements and clinical trends, but also an exceptional stage for researchers to share their findings and broaden their international perspectives.

The Korea WCLC will feature 18 session types and over 50 oral abstract presentations, focusing on the latest advancements across various domains including lung cancer risk control, biology, screening, local therapy, immunotherapy, and targeted therapy, centrally showcasing the year's key breakthroughs in lung cancer research.

Experts and scholars from around the world will gather to discuss cutting-edge topics such as precision medicine, immunotherapy, targeted therapy, early screening, and patient management through keynote speeches, specialized seminars, and poster sessions.

IASLC World Conference on Lung Cancer (WCLC) - Korea tickets are e-tickets. Domestic and international visitors must complete online pre-registration with real-name passport verification. After purchase, the organizer verifies visitor identity. Visitors who do not meet entry requirements may need to submit additional documents. Once approved, you will receive email confirmation or a QR code. On site, present your original passport and confirmation letter to collect a paper badge, or scan the QR code to enter.